News Sentiment

DTIL sentiment intelligence

Precision BioSciences Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 55 Balanced news tone 65 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 8.76 Week of 10 Jul 2026
Weighted tone 55/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

81/100 classification confidence.

Company focus 56

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend active

+7.1% over one week, +43.6% over four weeks, trend active, and near fair-value range.

Latest direct headline Positive

Trading the Move, Not the Narrative: (DTIL) Edition

Market Reaction

Price moving ahead of tone

64/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 81/100 classification
One-week reaction 7.1% Price confirming higher
Trend fit Trend active 43.6% over four weeks
Fair value 8.4% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 22
Neutral 38
Negative 5

Relevance

Why the article matched

Direct first
Direct company coverage 56
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
TradingView 9
Market source 8
Business Wire 7
GuruFocus 5
Stock Titan 4
www.marketscreener.com 3
simplywall.st 3
Quartr 2

Event Lens

What the news is about

Classified themes
Market update 39
Earnings 19
Analyst action 4
Deals and strategy 1
Regulatory and legal 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 65
TradingView Direct company coverage

Price to earnings forward of Precision BioSciences, Inc. – NASDAQ:DTIL

This article displays financial information for Precision BioSciences, Inc. (NASDAQ: DTIL), specifically focusing on its forward price-to-earnings ratio. It is presented in a format that appears to be a stub or a data point from a financial platform like TradingView, with no addi

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 05:40
Source
TradingView
TradingView Direct company coverage

Enterprise value to EBIT forward of Precision BioSciences, Inc. – LS:A400AS

This article provides financial information for Precision BioSciences, Inc. (A400AS) on the Lang & Schwarz Tradecenter. It specifically highlights the company's enterprise value to EBIT forward, presenting a quick snapshot of this financial metric. The content indicates the marke

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 00:40
Source
TradingView
Ad-hoc-news.de Direct company coverage

Precision BioSciences earnings calendar and gene-editing focus, shares remain a small-cap biotech pl

Precision BioSciences (DTIL) is a clinical-stage gene-editing company listed on Nasdaq, preparing for its next quarterly earnings update. The company focuses on its Arcus platform and in vivo gene-editing pipeline, with sufficient cash to fund operations into 2027. Analysts view

Tone
Positive 62/100
Event
Earnings
Published
25 Jun 2026 19:40
Source
Ad-hoc-news.de
Quartr Direct company coverage

Precision BioSciences (DTIL) AGM 2026 Summary

Precision BioSciences (DTIL) held its 2026 AGM on May 21, 2026, where the company highlighted significant progress in its lead programs, including encouraging Phase I data from the ELIMINATE-B trial for chronic hepatitis B. The company's financial position was strengthened by a $

Tone
Positive 70/100
Event
Market update
Published
19 Jun 2026 18:39
Source
Quartr
TradingKey Direct company coverage

Precision BioSciences Inc (DTIL) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Precision BioSciences Inc (DTIL), highlighting major shareholders and institutional holdings. It lists top individual shareholders by proportion and categorizes shareholder types, showing investment advisors and hedge funds as sig

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 12:09
Source
TradingKey
TradingKey Direct company coverage

Precision BioSciences Inc (DTIL) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Precision BioSciences Inc (DTIL) regarding its dividend history and stock splits. It states that no dividends have been distributed by the company over the past five years. However, it lists multiple instances of a 30-to-1 merger-related stock

Tone
Neutral 50/100
Event
Deals and strategy
Published
17 Jun 2026 12:09
Source
TradingKey
Stock Titan Direct company coverage

Precision BioSciences (NASDAQ: DTIL) amends loan and extends term to 2029

Precision BioSciences, Inc. has amended its Loan and Security Agreement with Banc of California, extending the maturity date of its Term Loan from June 30, 2027, to December 31, 2029. This amendment provides the company with over additional two years to repay the loan under the e

Tone
Positive 64/100
Event
Market update
Published
16 Jun 2026 20:09
Source
Stock Titan